3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Classical hematology
1
Conditions
Sarcopenia
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peripheral Nervous System Diseases
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid
1
Heart Failure
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Cardiotoxicity
1
Breast Neoplasms
1
Anemia, Aplastic
1
Interventions
fludarabine
7
Tacrolimus
6
Cyclophosphamide
6
Whole-Body Irradiation
5
Mycophenolic Acid
5
Busulfan
5
fludarabine phosphate
4
Peripheral Blood Stem Cell Transplantation
4
Imatinib Mesylate
4
Cytarabine
4
Sirolimus
3
Melphalan
3
thymoglobulin
2
asciminib
2
Thiotepa
2
Patient Reported Outcome Measures
2
Mesna
2
Bone Marrow Transplantation
2
Antilymphocyte Serum
2
venetoclax
1
ponatinib
1
pegfilgrastim
1
nilotinib
1
nicotinamide-beta-riboside
1
methanesulfonic acid
1
lonafarnib
1
lestaurtinib
1
glasdegib
1
flumatinib
1
aldesleukin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Leukemia, Myeloid
×
nicotinamide-beta-riboside
×
Clear all
NCT05194397
2025-12-04
IAMFIT
Children's Hospital of Philadelphia
Phase 2
Recruiting
80 enrolled